References

• Kronfol Z, Remick DG. Cytokines and brain: Implications for clinical psychiatry. Am J Psychiatry 2000; 157(5): 683–94.
   PubMed Web of Science ®Google Scholar
• Riedel M, Spellman I, Schwarz MJ, Strassnig M, Sikorski C, Möller HJ, et al. Decreased T cellular immune response in schizophrenic patients. J Psychiatr Res 2007; 41(1–2): 3–7.
   Web of Science ®Google Scholar
• Baker I, Masserano J, Wyatt RJ. Serum cytokine concentrations in patients with schizophrenia. Schizophr Res 1996; 20(1–2): 199–203.
   Web of Science ®Google Scholar
• Jones AL, Mowry BJ, Pender MP, Greer JM. Immune dysregulation and self-reactivity in schizophrenia: do some cases of schizophrenia have an autoimmune basis? Immunol Cell Biol 2005; 83(1): 9–17.
   PubMed Web of Science ®Google Scholar
• Strous R, Shoenfeld Y. Shizophrenia, autoimmunity and immune system dysregulation: a comprehensive model updated and revised. J Autoimmun 2006; 27(2): 71–80.
   PubMed Web of Science ®Google Scholar
• Jarskog LF, Xiao H, Wilkie MB, Lauder JM, Gilmore JH. Cytokine regulation of embryonic rat dopamine and serotonin neuronal survival in vitro. Int J Dev Neurosci 1997; 15(6): 711–6.
   PubMed Web of Science ®Google Scholar
• Araujo DM, Cotman CW. Differential effects of interleukin-1 beta and interleukin-2 on glia and hippocampal neurons in culture. Int J Dev Neurosci 1995; 13(3–4): 201–12.
   Web of Science ®Google Scholar
• Marx CE, Jarskog LF, Lauder JM, Lieberman JA, Gilmore JH. Cytokine effects on cortical neuron MAP-2 immunoreactivity: implications for schizophrenia. Biol Psychiatry 2001; 50(10): 743–9.
   Web of Science ®Google Scholar
• Chiesa C, Pellegrini G, Panero A, de Luca T, Assumma M, Signore F, et al. Umblical cord interleukin-6 levels are elevated in term neonates with perinatal asphyxia. Eur J Clin Invest 2003; 33(4): 352–8.
   Web of Science ®Google Scholar
• Silveira RC, Procianoy RS. Interleukin-6 and tumor necrosis factor-alpha levels in plasma and cerebrospinal fluid of term newborn infants with hypoxic-ischemic encephalopathy. J Pediatr 2003; 143(5): 625–9.
   Web of Science ®Google Scholar
• Giulian D, Young DG, Woodward J, Brown DC, Lachman LB. Interleukin-1 is an astroglial growth factor in the developing brain. J Neurosci 1988; 8(2): 443–9.
   Web of Science ®Google Scholar
• Maes M, Meltzer HY, Bosmans E. Immune-inflammatory markers in schizophrenia: comparison to normal controls and effects of clozapine. Acta Psychiatr Scand 1994; 89(5): 346–51.
   PubMed Web of Science ®Google Scholar
• Proost P, Wuyts A, van Damme J. The role of chemokines in inflammation. Int J Clin Lab Res 1996; 26(4): 211–23.
   Google Scholar
• Baggiolini M, Loetscher P, Moser B. Interleukin-8 and the chemokine family. Int J Immunopharmacol 1995; 17(2): 103–8.
   Web of Science ®Google Scholar
• American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, 4th ed. Washington DC, American Psychiatric Association, 1994.
   Google Scholar
• First MB, Spitzer RL, Gibbon M, Williams JBW. Structured Clinical Interview for DSM-IV Clinical Version. Washington D.C, American Psychiatric Press, 1997.
   Google Scholar
• Kaminska T, Wysocka A, Marmurowska-Michalowska H, Dubas-Slemp H, Kandefer-Szerszen M. Investigation of serum cytokine levels and cytokine production in whole blood cultures of paranoid schizophrenic patients. Arch Immunol Ther Exp 2001; 49(6): 439–44.
   Web of Science ®Google Scholar
• Nawa H, Take N. Recent progress in animal modeling of immune inflammatory processes in schizophrenia: implication of specific cytokines. Neurosci Res 2006; 56(1): 2–13.
   Web of Science ®Google Scholar
• Lai AY, Swayz RD, El-Husseini A, Song C. Interleukin-1 beta modulates AMPA receptor expression and phosphorylation in hippocampal neurons. J Neuroimmunol 2006; 175(1–2): 97–106.
   PubMed Web of Science ®Google Scholar
• Katila H, Appelberg B, Hurme M, Rimon R. Plasma levels of interleukin-1β and interleukin-6 in schizophrenia, other psychoses and affective disorders. Schizophrenia Res 1994; 12(1): 29–34.
   PubMed Web of Science ®Google Scholar
• Zalcman SS. Interleukin-2 induced increases in climbing behavior: inhibition by dopamine D-1 and D-2 receptor antagonists. Brain Res 2002; 944(1–2): 157–64.
   Web of Science ®Google Scholar
• Lapchak PA. A role of interleukin-2 in the regulatin of striatal dopomingergic function. Neuro Report 1992; 3(2): 165–8.
   Google Scholar
• Petitto JM, McCarthy DB, Rinker CM., Huang Z, Getty T. Modulation of behaviroal and neurochemical measures of forebrain dopamine function in mice by species-specific interleukin-2. J Neuroimmunol 1997; 73(1–2): 183–90.
   Web of Science ®Google Scholar
• Ganguli R, Brar JS, Chengappa KN, Deleo M, Yang ZW, Shurin G. Mitogen-stimulated interleukin-2 production in never-medicated, first-episode schizophrenic patients. Arch Gen Psychiatry 1995; 52(8): 668–72.
   Google Scholar
• Kim YK, Kim L, Lee MS. Relationships between interleukins, neurotransmitters and psychopathology in drug-free male schizophrenics. Schizophrenia Res 2000; 44(3): 165–75.
   Web of Science ®Google Scholar
• Wilke I, Arolt V, Rothermundt M, Weitzsch C, Hornberg M, Kirchner H. Investigations of cytokine production in whole blood cultures of paranoid and residual schizophrenic patients. Eur Arch Psychiatry Clin Neurosci 1996; 246(5): 279–84.
   Web of Science ®Google Scholar
• Gattaz WF, Dalgalarrondo P, Schroder HC. Abnormalities in serum concentrations of interleukin-2, interferon-alpha and interferon-gamma in schizophrenia not detected. Schizophr Res 1992; 6(3): 237–41.
   Web of Science ®Google Scholar
• Zhang XY, Zhou DF, Zhang PY, Wu GY, Cao LY, Shen YC. Elevated interleukin 2, interleukin-6 and interleukin-8 serum levels in neuroleptic-free schizophrenia: association with psychopathology. Schizophr Res 2002; 57(2–3): 247–58.
   Web of Science ®Google Scholar
• Van Kammen DP, McAllister-Sistilli CG, Kelley ME, Gurklis JA, Yao JK. Elevated interleukin-6 in schizophrenia. Psychiatry Res 1999; 87(2–3): 129–36.
   Web of Science ®Google Scholar
• Ringheim GE, Burgher KL, Heroux JA. Interleukin-6 mRNA statement by cortical neurons in culture: evidence for neuronal sources of intereukin-6 production in the brain. J Neuro Immunol 1995; 63(2): 113–23.
   PubMed Web of Science ®Google Scholar
• Kahn MA, de Vellis J. Regulation of an oligodendrocyte progenitor cell line by the interleukin-6 family of cytokines. Glia 1994; 12(2): 87–98.
   Web of Science ®Google Scholar
• Qiu Z, Sweeney DD, Netzeband JG, Gruol DL. Chronic interleukin-6 alters NMDA receptor-mediated membrane responses and enhances neurotoxicity in developing CNS neurons. J Neurosci 1998; 18(24): 10445–6.
   Web of Science ®Google Scholar
• Spangelo B, Isakson PC, MacLeod RM. IL-6 stimulates anterior pituitary hormones release in vitro. Endocrinology 1989; 125(1): 575–7.
   Web of Science ®Google Scholar
• Hirano T, Akira S, Taga T, Kishimoto T. Biological and clinical aspects of interleukin-6. Immunol Today 1990; 11(12): 443–9.
   Google Scholar
• Cronstein BN. Interleukin-6 a key mediator of systemic and local symptoms in rheumatoid arthritis. Bull NYU Hosp Jt Dis 2007; 65 (Suppl. 1): 11–5.
   PubMedGoogle Scholar
• Shintani F, Shigenobu K, Maruo N, Nakaki T, Nibuya M, Suzuki E et al. Serum interleukin-6 in schizophrenic patients. Life Sci 1991; 49(9): 661–4.
   Web of Science ®Google Scholar
• Turkoglu A, Sengul C, Okay T, Dilbaz N. Serum IL-6 and IL-8 levels in schizophrenia and changes with antipsychotic treatment. Klinik Psikofarmakoloji Bulteni-Bulletin of Clinical Psychopharmacology 2007; 17(2): 55–61.
   Google Scholar
• Maggiore G, de Benedetti F, Massa M, Pignatti P, Martini A. Circulation levels of interleukin-6, interleukin-8 and tumor necrosis factor-alpha in children with autoimmune hepatitis. J Pediatr Gastroenterol Nutr 1995; 20(1): 23–7.
   Web of Science ®Google Scholar
• Yum SY, Yum SK, Kim T, Hwang MY. Clinical perspectives on autoimmune processes in schizophrenia. Psychiatr Clin North Am 2009; 32(4): 795–808.
   Web of Science ®Google Scholar
• Uppal SS, Raghupathy R, Hayat SJ, Chowdhury RI, Abraham M, Rawoot P. Patient demographics and disease variables correlate with distinct cytokine patterns in mitogen-stimulated peripheral blood mononuclear cells from rheumatoid arthritis patients. Rheumatol Int 2008; 28(6): 533–9.
   Web of Science ®Google Scholar
• Haack M, Hinze-Selch D, Fenzel T, Kraus T, Kühn M, Pollmacher T. Plasma levels of cytokines and soluble cytokine receptors in psychiatric patients; effects of confounding factors and diagnosis. J Psychiatry Res 1999; 33(5): 407–18.
   Web of Science ®Google Scholar
• Black PH. The inflammatory consequences of psychologic stress: relationship to insulin resistance, obesity, atherosclerosis and diabetes mellitus, type II. Med Hypotheses 2006; 67(4): 879–91.
   Web of Science ®Google Scholar
• Watanabe Y, Someya T, Nawa H. Cytokine hypothesis of schizophrenia pathogenesis: evidence from human studies and animal models. Psychiatry Clin Neurosci 2010; 64(3): 217–30.
   Web of Science ®Google Scholar
• Janssen DG, Caniato RN, Verster JC, Baune BT. A psychoneuroimmunological review on cytokines involved in antidepressant treatment response. Hum Psychopharmacol 2010; 25(3): 201–15.
   PubMed Web of Science ®Google Scholar